HealthEquity Net Debt vs Long Term Debt Total Analysis
HQY Stock | USD 79.21 0.81 1.03% |
HealthEquity financial indicator trend analysis is much more than just examining HealthEquity latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether HealthEquity is a good investment. Please check the relationship between HealthEquity Net Debt and its Long Term Debt Total accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HealthEquity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index. For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.
Net Debt vs Long Term Debt Total
Net Debt vs Long Term Debt Total Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of HealthEquity Net Debt account and Long Term Debt Total. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between HealthEquity's Net Debt and Long Term Debt Total is -0.14. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Long Term Debt Total in the same time period over historical financial statements of HealthEquity, assuming nothing else is changed. The correlation between historical values of HealthEquity's Net Debt and Long Term Debt Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of HealthEquity are associated (or correlated) with its Long Term Debt Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt Total has no effect on the direction of Net Debt i.e., HealthEquity's Net Debt and Long Term Debt Total go up and down completely randomly.
Correlation Coefficient | -0.14 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Net Debt
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.Long Term Debt Total
Most indicators from HealthEquity's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into HealthEquity current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HealthEquity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index. For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.At this time, HealthEquity's Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to rise to about 20.3 M in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.08 in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 423.7M | 490.1M | 529.9M | 556.4M | Total Revenue | 756.6M | 861.7M | 999.6M | 1.0B |
HealthEquity fundamental ratios Correlations
Click cells to compare fundamentals
HealthEquity Account Relationship Matchups
High Positive Relationship
High Negative Relationship
HealthEquity fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 2.6B | 2.7B | 3.1B | 3.1B | 3.2B | 3.4B | |
Other Current Liab | 96.7M | 126.2M | 104.7M | 89.5M | 95.6M | 54.8M | |
Total Current Liabilities | 152.1M | 204.3M | 153.2M | 131.1M | 117.1M | 79.0M | |
Total Stockholder Equity | 1.0B | 1.4B | 1.9B | 1.9B | 2.0B | 2.1B | |
Other Liab | 133.1M | 128.5M | 114.0M | 95.4M | 109.7M | 115.2M | |
Accounts Payable | 4.0M | 1.6M | 27.5M | 13.9M | 12.0M | 6.9M | |
Cash | 191.7M | 328.8M | 225.4M | 254.3M | 404.0M | 212.6M | |
Other Assets | 35.1M | 37.4M | 49.8M | 52.2M | 1.0 | 0.95 | |
Good Will | 1.3B | 1.3B | 1.6B | 1.6B | 1.9B | 2.0B | |
Common Stock Shares Outstanding | 68.5M | 75.7M | 83.1M | 84.4M | 87.0M | 68.4M | |
Other Current Assets | 33.8M | 58.6M | 38.5M | 31.8M | 48.6M | 51.0M | |
Total Liab | 1.5B | 1.3B | 1.3B | 1.2B | 1.2B | 609.8M | |
Intangible Assets | 783.3M | 767.0M | 973.1M | 936.4M | 835.9M | 428.2M | |
Property Plant Equipment | 33.5M | 118.6M | 87.0M | 69.3M | 79.7M | 83.7M | |
Property Plant And Equipment Net | 116.7M | 118.6M | 87.0M | 69.3M | 54.4M | 47.5M | |
Net Debt | 1.1B | 746.2M | 782.8M | 740.2M | 529.2M | 299.8M | |
Retained Earnings | 211.5M | 220.3M | 176.1M | 149.9M | 205.6M | 121.8M | |
Non Current Assets Total | 2.3B | 2.2B | 2.8B | 2.7B | 2.7B | 2.8B | |
Cash And Short Term Investments | 191.7M | 328.8M | 225.4M | 254.3M | 404.0M | 243.5M | |
Net Receivables | 70.5M | 72.8M | 87.4M | 96.8M | 104.9M | 52.6M | |
Liabilities And Stockholders Equity | 2.6B | 2.7B | 3.1B | 3.1B | 3.2B | 1.6B | |
Non Current Liabilities Total | 1.4B | 1.1B | 1.1B | 1.1B | 1.1B | 578.7M | |
Other Stockholder Equity | 818.8M | 1.2B | 1.7B | 1.7B | 1.8B | 1.9B | |
Property Plant And Equipment Gross | 116.7M | 118.6M | 87.0M | 69.3M | 95.4M | 51.6M | |
Total Current Assets | 296.0M | 460.2M | 351.3M | 382.9M | 557.4M | 320.0M | |
Net Tangible Assets | (1.1B) | (715.1M) | (766.4M) | (688.9M) | (620.0M) | (589.0M) | |
Non Currrent Assets Other | 35.1M | 37.4M | 49.8M | 52.2M | (768.1M) | (729.7M) | |
Retained Earnings Total Equity | 85.3M | 171.9M | 211.5M | 220.3M | 253.4M | 266.1M | |
Capital Surpluse | 261.2M | 305.2M | 818.8M | 1.2B | 1.3B | 1.4B | |
Non Current Liabilities Other | 1.4B | 8.8M | 14.2M | 12.7M | 19.3M | 18.3M | |
Net Invested Capital | 2.3B | 2.4B | 2.8B | 2.8B | 2.9B | 2.2B | |
Net Working Capital | 145.4M | 255.5M | 198.2M | 251.8M | 440.3M | 298.8M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.C | Citigroup | |
CRM | Salesforce | |
MSFT | Microsoft |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HealthEquity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index. For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for HealthEquity Stock analysis
When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
CEOs Directory Screen CEOs from public companies around the world | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |
Is HealthEquity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HealthEquity. If investors know HealthEquity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HealthEquity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.96) | Earnings Share 0.64 | Revenue Per Share 11.682 | Quarterly Revenue Growth 0.122 | Return On Assets 0.0256 |
The market value of HealthEquity is measured differently than its book value, which is the value of HealthEquity that is recorded on the company's balance sheet. Investors also form their own opinion of HealthEquity's value that differs from its market value or its book value, called intrinsic value, which is HealthEquity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HealthEquity's market value can be influenced by many factors that don't directly affect HealthEquity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HealthEquity's value and its price as these two are different measures arrived at by different means. Investors typically determine if HealthEquity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HealthEquity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.